Skip to main content
GutCited

Lactase Hình ảnh

20 hình ảnh từ nghiên cứu có bình duyệt

Tất cả Psyllium Husk Bifidobacterium lactis Fructooligosaccharides (FOS) Lactobacillus plantarum Peppermint Oil Pancreatic Enzymes (Pancrelipase) Curcumin Vitamin A Medium-Chain Triglycerides (MCT Oil) Galactooligosaccharides (GOS) Lactobacillus gasseri Aloe Vera (Inner Leaf Gel) Alpha-Galactosidase Vitamin D L-Glutamine Inulin Ginger Lactase Berberine Omega-3 Fatty Acids (EPA/DHA) Bovine Colostrum Zinc Bifidobacterium bifidum Butyrate (Sodium/Calcium Butyrate) Bacillus coagulans Saccharomyces boulardii Lactobacillus acidophilus N-Acetyl Cysteine (NAC) Bifidobacterium longum
All Types Chart Diagram Photograph Flowchart Forest Plot Micrograph Other
Figure 1. Map of the lactase (LCT) and minichromosome maintenance 6 (MCM6) gene region and location of genotyped single nucleotide polymorphisms (SNPs). (a) Distribution of 123 SNPs included in genotype analysis; (b) map of the LCT and MCM6 gene region; (
Figure 1 Diagram

Genetic map of the lactase (LCT) and MCM6 gene region displays the locations of key single nucleotide polymorphisms associated with lactase persistence and non-persistence phenotypes across populations.

Lactose Intolerance in Adults: Biological Mechanism and Dietary Management.

Figure 2. Small bowel water content (SBWC) and breath hydrogen (H2) concentrations after drinking each of the drinks: glucose and fructose. The time of drinking (t = 0 min) is highlighted in the chart. Values of SBWC are mean volume (mL) ˘ s.e.m (standard
Figure 2 Chart

Small bowel water content and breath hydrogen concentrations after consuming glucose and fructose drinks are plotted over time, providing reference data for comparison with lactose challenge tests.

Lactose Intolerance in Adults: Biological Mechanism and Dietary Management.

Figure 3. Prevalence of lactose malabsorption (LM) and lactose intolerance (LI) in patients with diarrhea predominant irritable bowel syndrome (IBS-D) and controls at 10-, 20-, and 40-g lactose hydrogen breath test (HBTs). * p < 0.05; ** p < 0.01 [3
Figure 3 Chart

Prevalence of lactose malabsorption versus symptomatic lactose intolerance in IBS-D patients is compared, demonstrating that malabsorption does not invariably produce clinical symptoms.

Lactose Intolerance in Adults: Biological Mechanism and Dietary Management.

Figure 4. Representative photomicrographs showing tryptase positive mast cells (MCs) in the colonic mucosa of a healthy control (HCs) (a–c); an diarrhea predominant irritable bowel syndrome (IBS-D) patient with lactose malabsorption (LM) (d–f) and a patie
Figure 4 Micrograph

Representative photomicrographs of tryptase-positive mast cells in colonic mucosa compare healthy controls with IBS-D patients, suggesting mast cell involvement in lactose intolerance symptomatology.

Lactose Intolerance in Adults: Biological Mechanism and Dietary Management.

Figure 5
Figure 5 Diagram

Dietary management strategies for lactose intolerance are summarized, including enzyme supplementation, dairy product selection, and gradual tolerance-building approaches.

Lactose Intolerance in Adults: Biological Mechanism and Dietary Management.

Figure 2. Representation of the geographic distributions of lactase non persistence frequencies of populations in the world.
Figure 5 Diagram

Geographic distribution of lactase non-persistence frequencies reveals wide variation across world populations, with highest persistence rates in Northern European and certain African and Middle Eastern pastoralist populations. East Asian and Native American populations show near-universal non-persistence.

Lactose Intolerance, Dairy Avoidance, and Treatment Options.

Figure 1. In the presence of an adequate amount of lactase, lactose is hydrolysed into galactose (Gal) and glucose (Glu), which are rapidly absorbed into the bloodstream, together with H2O molecules (modified from [5]).
Figure 5 Diagram

Schematic showing the enzymatic hydrolysis of lactose by lactase into galactose and glucose, which are then absorbed into the bloodstream. In lactase-sufficient individuals, this process occurs efficiently in the small intestinal brush border.

Lactose Maldigestion, Malabsorption, and Intolerance: A Comprehensive Review with a Focus on …

Figure 2. Some of the most important single nucleotide polymorphisms in the lactase gene (modified from [13]).
Figure 6 Diagram

Map of key single nucleotide polymorphisms (SNPs) in the lactase gene that regulate lactase persistence into adulthood. These genetic variants explain much of the population-level variation in the ability to digest lactose.

Lactose Maldigestion, Malabsorption, and Intolerance: A Comprehensive Review with a Focus on …

Figure 1. Bone mass throughout the life span. Bone accumulates rapidly in childhood and grows at maximal rates during puberty. Peak bone mass is reached by age 30, and then slowly decreases. Females typically accumulate less bone mass than males and rapid
Figure 5 Chart

Bone mass changes throughout the human lifespan are charted, showing rapid accumulation during childhood, peak bone mass around age 30, and subsequent gradual decline. Females typically experience accelerated bone loss after menopause, underscoring the importance of adequate calcium intake in earlier decades.

Lactose Intolerance and Bone Health: The Challenge of Ensuring Adequate Calcium Intake.

Figure 5
Figure 5 Chart

Alpha diversity indices of fecal microbiota are plotted for treated versus placebo groups, indicating whether probiotic supplementation altered overall bacterial community richness.

Effects of Bifidobacterium longum and Lactobacillus rhamnosus on Gut Microbiota in Patients …

Figure 6
Figure 6 Chart

Lactose tolerance test outcomes are compared between intervention groups, with symptom severity mapped against breath hydrogen concentrations.

Effects of Bifidobacterium longum and Lactobacillus rhamnosus on Gut Microbiota in Patients …

Figure 1. Consort flow-chart of screened patients. Starting from a general group of 135 symptomatic patients, and after exclusion of 21 patients with organic diseases, a subgroup of 114 patients had functional gastrointestinal symptoms. After further exclu
Figure 7 Flowchart

A CONSORT flow chart traces patient screening and enrollment for this trial of Bifidobacterium longum and Lactobacillus rhamnosus in lactose-intolerant individuals, detailing exclusions for organic diseases and final group assignments.

Effects of Bifidobacterium longum and Lactobacillus rhamnosus on Gut Microbiota in Patients …

Figure 8
Figure 8 Chart

Fecal short-chain fatty acid concentrations are measured across treatment groups, reflecting metabolic activity changes in the gut microbiome following probiotic administration.

Effects of Bifidobacterium longum and Lactobacillus rhamnosus on Gut Microbiota in Patients …

Figure 3. Representation of bloating (visual analogue scale (VAS) 0–100 mm) in 23 patients at baseline (T0) and after 30 days (T30) of treatment (ZR) and placebo (PL) by spaghetti graft.
Figure 9 Chart

Individual patient trajectories for bloating severity, measured on a 0-100 mm visual analogue scale, are plotted at baseline and after 30 days for both the probiotic treatment and placebo groups.

Effects of Bifidobacterium longum and Lactobacillus rhamnosus on Gut Microbiota in Patients …

Figure 10
Figure 10 Chart

Symptom improvement scores for lactose-intolerant patients receiving a combined Bifidobacterium longum and Lactobacillus rhamnosus preparation are compared with placebo responses over the treatment period.

Effects of Bifidobacterium longum and Lactobacillus rhamnosus on Gut Microbiota in Patients …

Figure 4. Relative proportions (percent) of phylum in the fecal samples of treated patients (ZR) and those of placebo (PL) patients.
Figure 11 Chart

Relative proportions of bacterial phyla in fecal samples are compared between probiotic-treated and placebo groups, revealing shifts in gut microbiota composition following Bifidobacterium longum and Lactobacillus rhamnosus supplementation.

Effects of Bifidobacterium longum and Lactobacillus rhamnosus on Gut Microbiota in Patients …

Figure 12
Figure 12 Chart

Hydrogen breath test results before and after probiotic supplementation are presented, indicating alterations in lactose fermentation patterns associated with treatment.

Effects of Bifidobacterium longum and Lactobacillus rhamnosus on Gut Microbiota in Patients …

Figure 5. Relative proportions (percent) of genera showing significant (p < 0.05) differences between the fecal samples of treated patients (ZR) and those of placebo (PL) patients.
Figure 13 Chart

Bacterial genera showing statistically significant differences between probiotic-treated and placebo patients are depicted, highlighting specific microbial populations responsive to Bifidobacterium and Lactobacillus supplementation.

Effects of Bifidobacterium longum and Lactobacillus rhamnosus on Gut Microbiota in Patients …

Intolerance symptoms are caused by the osmotic effect of lactose on the intestinal lumen and by the fermentation effect of colonic bacteria that produce gases, such as hydrogen, carbon dioxide, and methane (H2, CO2, and CH4), acid and harmful metabolites.
Figure 1 Diagram

Pathophysiology of lactose intolerance illustrating how undigested lactose causes symptoms through osmotic effects in the intestinal lumen and bacterial fermentation producing hydrogen, carbon dioxide, and methane gases.

Lactose intolerance: myths and facts. An update.

Figure 2
Figure 2 Diagram

Diagnostic algorithm or classification scheme for lactose intolerance, distinguishing between primary (genetic), secondary (disease-related), and congenital forms of lactase deficiency.

Lactose intolerance: myths and facts. An update.